Sulzer goes for organic growth rather than giant acquisition
This article was originally published in Clinica
Executive Summary
"A large acquisition is not essential for ensuring the future of Sulzer Medica." This statement from Sulzer last week is in sharp contrast to strong hints of a major purchase in one of its medical businesses less than a year ago when the group chairman predicted a $1 billion healthcare purchase.